Eurofins Scientific SE Stock
Stocks
ERF
FR0014000MR3
Biotechnology & Medical Research
OTC Markets Traded|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.88 EUR | +1.68% |
|
+0.50% | +10.35% |
| 07-23 | Eurofins Scientific SE, H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Eurofins Scientific: BioPharma's slowdown raises questions on 2026 organic growth target |  |
| Market Cap | 11.76B 13.53B 10.98B 10.08B 19B 1,290B 19.34B 129B 50.7B 643B 50.82B 49.7B 2,121B | P/E 2026 * |
22.5x | P/E 2027 * | 17.8x |
|---|---|---|---|---|---|
| Enterprise Value | 15.03B 17.29B 14.03B 12.88B 24.28B 1,648B 24.71B 165B 64.79B 822B 64.94B 63.51B 2,711B | EV / Sales 2026 * |
1.98x | EV / Sales 2027 * | 1.83x |
| Free-Float |
60.39% | Yield 2026 * |
1.17% | Yield 2027 * | 1.34% |
Last Transcript: Eurofins Scientific SE
| 1 day | +1.65% | ||
| 1 week | +0.50% | ||
| Current month | +1.03% | ||
| 1 month | +0.23% | ||
| 3 months | +19.01% | ||
| 6 months | +1.50% | ||
| Current year | +10.35% |
| 1 week | 67.16 |  | 69.26 |
| 1 month | 64.56 | | 71.28 |
| Current year | 56.84 | | 74.32 |
| 1 year | 54.86 | | 74.32 |
| 3 years | 39.47 | | 74.32 |
| 5 years | 39.47 | | 127.68 |
| 10 years | 29.82 | | 127.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 63 | 1986-12-31 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 2014-12-31 |
Christian Wurst
PRN | Corporate Officer/Principal | 53 | 2019-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 63 | 1986-12-31 |
Yves-Loïc Martin
BRD | Director/Board Member | 60 | 2014-12-31 |
Valérie Hanote
BRD | Director/Board Member | 60 | 1989-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/27/26 | Buy | Chief Executive Officer | 1,000 | 0.0005% | ||
| 2/27/26 | Buy | Chief Executive Officer | 1,000 | 0.0005% | ||
| 2/27/26 | Buy | Chief Executive Officer | 1,000 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.68% | +0.50% | +3.49% | +16.87% | 13.53B | |
| +0.18% | -0.07% | -1.03% | +13.55% | 48.22B | |
| -2.71% | -2.99% | +398.09% | +472.12% | 38.79B | |
| -0.71% | +9.45% | +27.90% | +7.89% | 38.41B | |
| -0.71% | -3.72% | +4.94% | +52.45% | 34.88B | |
| -2.41% | +1.96% | +11.68% | +38.17% | 29.19B | |
| -0.66% | -2.73% | +35.50% | +122.17% | 16B | |
| -0.19% | -3.93% | - | - | 16.05B | |
| -3.15% | -6.14% | -4.82% | -36.90% | 12.22B | |
| +0.07% | +0.73% | +31.43% | -10.95% | 11.24B | |
| Average | -0.45% | -0.52% | +56.35% | +75.04% | 25.85B | |
| Weighted average by Cap. | -0.34% | +0.18% | +73.76% | +98.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.59B 8.74B 7.09B 6.51B 12.27B 833B 12.48B 83.57B 32.73B 415B 32.81B 32.08B 1,369B | 8.01B 9.22B 7.48B 6.87B 12.95B 879B 13.18B 88.21B 34.55B 438B 34.63B 33.87B 1,446B |
| Net income | 522M 600M 487M 447M 843M 57.21B 858M 5.74B 2.25B 28.53B 2.25B 2.2B 94.1B | 656M 755M 612M 562M 1.06B 71.95B 1.08B 7.22B 2.83B 35.88B 2.84B 2.77B 118B |
| Net Debt | 3.27B 3.76B 3.05B 2.8B 5.28B 358B 5.37B 35.96B 14.08B 179B 14.12B 13.81B 589B | 2.87B 3.3B 2.68B 2.46B 4.63B 314B 4.71B 31.56B 12.36B 157B 12.39B 12.12B 517B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | €68.88 | +1.68% | 54,369 |
| 26-08-03 | €67.74 | -0.62% | 214,239 |
| 26-07-31 | €68.16 | -0.64% | 183,678 |
| 26-07-30 | €68.60 | -0.06% | 185,738 |
| 26-07-29 | €68.64 | +0.18% | 182,423 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ERF Stock
Select your edition
All financial news and data tailored to specific country editions
